Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Bryan Haugen

Concepts (503)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
95
2025
310
16.670
 Why?
Iodine Radioisotopes
29
2025
143
3.870
 Why?
Thyroid Nodule
18
2025
55
3.780
 Why?
Adenocarcinoma, Follicular
19
2024
34
3.710
 Why?
Carcinoma, Papillary
24
2017
77
3.550
 Why?
Thyroid Gland
26
2018
94
3.410
 Why?
Endocrinology
10
2020
74
3.140
 Why?
Thyrotropin
30
2023
109
2.800
 Why?
Carcinoma
10
2025
215
1.870
 Why?
Thyroid Diseases
8
2020
35
1.500
 Why?
Thyroidectomy
17
2024
87
1.430
 Why?
Antineoplastic Agents
15
2022
2054
1.310
 Why?
Retinoid X Receptors
11
2011
41
1.310
 Why?
Retinoids
7
2011
33
1.230
 Why?
Hypothyroidism
8
2023
70
1.200
 Why?
Tetrahydronaphthalenes
6
2015
30
1.190
 Why?
Thyroid Carcinoma, Anaplastic
6
2019
35
1.180
 Why?
Biomarkers, Tumor
15
2024
1173
1.090
 Why?
Thyroxine
12
2023
62
1.090
 Why?
Receptors, Retinoic Acid
7
2004
51
1.030
 Why?
Biopsy, Fine-Needle
9
2021
68
0.970
 Why?
NF-kappa B
3
2015
665
0.960
 Why?
Lymphatic Metastasis
7
2024
320
0.920
 Why?
Ultrasonography
8
2025
713
0.910
 Why?
Carcinoma, Papillary, Follicular
4
2014
8
0.910
 Why?
Neoplasm Proteins
6
2013
422
0.860
 Why?
Transcription Factors
15
2014
1647
0.850
 Why?
Gene Expression Profiling
6
2020
1688
0.830
 Why?
Thyroglobulin
8
2024
27
0.820
 Why?
Cell Line, Tumor
19
2020
3202
0.820
 Why?
Humans
135
2025
129266
0.790
 Why?
Radiopharmaceuticals
3
2012
168
0.780
 Why?
Struma Ovarii
2
2014
7
0.780
 Why?
Proto-Oncogene Proteins B-raf
3
2023
209
0.720
 Why?
Neoplasm Invasiveness
6
2017
483
0.700
 Why?
Thiazolidinediones
4
2018
137
0.700
 Why?
Promoter Regions, Genetic
14
2018
1204
0.700
 Why?
Pituitary Gland
6
2011
148
0.690
 Why?
History, 20th Century
7
2018
291
0.670
 Why?
Oncogene Proteins, Fusion
2
2019
200
0.670
 Why?
Lymph Nodes
5
2018
470
0.650
 Why?
Cell Differentiation
5
2020
1887
0.630
 Why?
Neoplasm Recurrence, Local
8
2024
958
0.610
 Why?
T-Lymphocytes, Regulatory
3
2015
373
0.610
 Why?
Triiodothyronine
4
2017
44
0.600
 Why?
Neoplasm Metastasis
10
2015
610
0.600
 Why?
History, 21st Century
6
2018
183
0.580
 Why?
Hypothalamus
2
2011
149
0.570
 Why?
Proto-Oncogene Proteins p21(ras)
1
2019
259
0.560
 Why?
Societies, Medical
6
2020
744
0.550
 Why?
Mutation
11
2023
3710
0.550
 Why?
Recombinant Proteins
9
2009
1304
0.550
 Why?
Programmed Cell Death 1 Receptor
3
2016
232
0.540
 Why?
Neoplasm Staging
14
2021
1290
0.530
 Why?
Ovarian Neoplasms
2
2014
489
0.520
 Why?
Multimodal Imaging
2
2014
110
0.520
 Why?
Molecular Targeted Therapy
3
2015
390
0.510
 Why?
Pharmacogenomic Testing
1
2016
61
0.500
 Why?
Drug Resistance, Neoplasm
3
2016
756
0.500
 Why?
Transcriptome
3
2020
874
0.500
 Why?
DNA-Binding Proteins
13
2014
1446
0.490
 Why?
Terminology as Topic
1
2017
203
0.490
 Why?
Protein-Tyrosine Kinases
1
2019
432
0.480
 Why?
Databases, Genetic
1
2016
230
0.480
 Why?
Thyroid Hormones
4
2020
55
0.470
 Why?
Famous Persons
1
2014
7
0.470
 Why?
Tomography, Emission-Computed, Single-Photon
2
2014
77
0.460
 Why?
Anticarcinogenic Agents
1
2015
77
0.450
 Why?
Immunotherapy, Adoptive
1
2017
295
0.450
 Why?
Physician Executives
1
2014
33
0.450
 Why?
Data Collection
3
2016
647
0.450
 Why?
Reverse Transcriptase Polymerase Chain Reaction
9
2014
947
0.450
 Why?
Hyperthyroidism
2
2012
28
0.440
 Why?
Gene Expression Regulation, Neoplastic
7
2018
1344
0.440
 Why?
Mice
28
2022
16915
0.440
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1556
0.440
 Why?
Genes, Tumor Suppressor
1
2014
86
0.430
 Why?
Neoplasm Transplantation
5
2019
256
0.430
 Why?
Combined Modality Therapy
8
2021
1199
0.420
 Why?
Gene Expression
2
2012
1466
0.420
 Why?
Medical Oncology
1
2016
270
0.420
 Why?
Interleukin-8
1
2014
262
0.410
 Why?
Middle Aged
36
2024
31090
0.400
 Why?
Phenylurea Compounds
2
2024
89
0.400
 Why?
Research
1
2016
416
0.400
 Why?
RNA, Messenger
15
2012
2703
0.390
 Why?
Proteomics
3
2010
1054
0.390
 Why?
Neovascularization, Pathologic
1
2014
296
0.390
 Why?
Quinolines
2
2024
156
0.380
 Why?
Radiotherapy, Adjuvant
2
2012
208
0.380
 Why?
Pituitary Gland, Anterior
4
2002
39
0.380
 Why?
Female
52
2024
68551
0.380
 Why?
Cell Proliferation
9
2019
2375
0.380
 Why?
Decision Support Techniques
1
2015
395
0.370
 Why?
Animals
32
2022
35309
0.370
 Why?
Practice Guidelines as Topic
5
2020
1497
0.360
 Why?
Bone Neoplasms
2
2012
231
0.360
 Why?
Protein Kinase Inhibitors
3
2024
890
0.360
 Why?
Telomerase
5
2019
233
0.350
 Why?
Prognosis
12
2024
3773
0.350
 Why?
DNA, Neoplasm
2
2008
158
0.350
 Why?
Aged
25
2024
22032
0.350
 Why?
Male
46
2024
63512
0.340
 Why?
Blotting, Western
8
2014
1204
0.340
 Why?
PPAR gamma
3
2009
183
0.340
 Why?
Carrier Proteins
1
2014
742
0.330
 Why?
T-Lymphocytes
2
2017
1933
0.330
 Why?
MAP Kinase Kinase 2
1
2009
29
0.320
 Why?
Cell Culture Techniques
2
2009
336
0.320
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2009
12
0.320
 Why?
MAP Kinase Kinase 1
1
2009
76
0.310
 Why?
Forkhead Transcription Factors
1
2010
184
0.310
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2009
35
0.310
 Why?
Treatment Outcome
18
2024
10202
0.300
 Why?
Iodide Peroxidase
2
2005
28
0.300
 Why?
Adult
34
2024
35495
0.290
 Why?
Hormone Replacement Therapy
2
2020
92
0.290
 Why?
Benzodioxoles
1
2009
105
0.290
 Why?
Receptors, Cytoplasmic and Nuclear
2
2009
217
0.280
 Why?
Quinazolines
1
2009
244
0.280
 Why?
Cell Transformation, Neoplastic
2
2012
327
0.280
 Why?
Signal Transduction
5
2016
4926
0.280
 Why?
MAP Kinase Signaling System
1
2009
313
0.280
 Why?
Adenoma
3
2025
214
0.270
 Why?
Retrospective Studies
12
2025
14461
0.270
 Why?
S100 Proteins
1
2006
36
0.260
 Why?
Disease-Free Survival
5
2021
645
0.260
 Why?
Adenoma, Oxyphilic
2
2024
6
0.260
 Why?
Diagnosis, Differential
6
2025
1432
0.260
 Why?
Lipoprotein Lipase
2
2004
59
0.250
 Why?
Tomography, X-Ray Computed
3
2018
2515
0.250
 Why?
Apoptosis
4
2012
2499
0.250
 Why?
Evidence-Based Medicine
3
2020
712
0.250
 Why?
Neoplasms
3
2016
2449
0.250
 Why?
Molecular Diagnostic Techniques
2
2021
98
0.250
 Why?
Mice, Nude
5
2018
682
0.240
 Why?
Oligonucleotide Array Sequence Analysis
3
2014
756
0.240
 Why?
Melanoma
2
2009
729
0.240
 Why?
Tumor Cells, Cultured
8
2009
942
0.230
 Why?
Goiter, Nodular
1
2004
2
0.230
 Why?
Retinoid X Receptor gamma
1
2004
4
0.230
 Why?
Sensitivity and Specificity
6
2024
1839
0.230
 Why?
Chromosomal Proteins, Non-Histone
2
2002
116
0.230
 Why?
Galectin 3
1
2004
20
0.230
 Why?
Dietary Fats
2
2004
301
0.230
 Why?
United States
13
2023
13826
0.220
 Why?
Immunohistochemistry
7
2020
1691
0.220
 Why?
Microtubule-Associated Proteins
2
2002
192
0.220
 Why?
Radionuclide Imaging
4
2010
123
0.220
 Why?
Molecular Sequence Data
13
2006
2835
0.210
 Why?
Drug Resistance
2
2022
166
0.210
 Why?
Cell Line
4
2022
2779
0.210
 Why?
Whole-Body Counting
2
2006
6
0.210
 Why?
Prospective Studies
12
2023
7123
0.210
 Why?
Aged, 80 and over
10
2024
7055
0.200
 Why?
Tamoxifen
2
2020
199
0.200
 Why?
Cell Cycle Proteins
1
2006
584
0.200
 Why?
Benzoates
3
2009
41
0.190
 Why?
Disease Models, Animal
4
2022
4057
0.190
 Why?
Reoperation
1
2024
541
0.190
 Why?
Cytodiagnosis
1
2021
32
0.190
 Why?
Xenograft Model Antitumor Assays
4
2020
812
0.180
 Why?
Lymphoma
1
2002
196
0.180
 Why?
Polymorphism, Single Nucleotide
1
2008
2063
0.180
 Why?
Thyroid Hormone Resistance Syndrome
1
2000
1
0.170
 Why?
Base Sequence
11
2002
2146
0.170
 Why?
Consensus
3
2020
615
0.170
 Why?
Carcinoma, Neuroendocrine
1
2020
32
0.170
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3
2010
136
0.170
 Why?
Adenocarcinoma
3
2017
898
0.160
 Why?
CD8-Positive T-Lymphocytes
3
2016
857
0.160
 Why?
Antibodies, Monoclonal, Humanized
1
2024
758
0.160
 Why?
Vascular Endothelial Growth Factor A
1
2022
530
0.160
 Why?
Nitriles
2
2010
172
0.150
 Why?
Transfection
5
2005
915
0.150
 Why?
Thyrotropin, beta Subunit
2
2011
5
0.140
 Why?
Receptors, Estrogen
1
2020
426
0.140
 Why?
Algorithms
5
2018
1613
0.140
 Why?
Workflow
1
2018
155
0.140
 Why?
Antigens, Neoplasm
1
2020
308
0.140
 Why?
Up-Regulation
1
2020
839
0.140
 Why?
Neck
2
2015
94
0.140
 Why?
Intercellular Adhesion Molecule-1
1
2017
135
0.140
 Why?
Tissue Extracts
1
2017
19
0.140
 Why?
Heterografts
2
2015
131
0.140
 Why?
Disease Progression
6
2020
2630
0.130
 Why?
Transcription Factor Pit-1
8
1999
24
0.130
 Why?
Muscle, Skeletal
2
2004
1613
0.130
 Why?
Parathyroidectomy
1
2016
7
0.130
 Why?
Enzyme Inhibitors
2
2010
827
0.130
 Why?
Tretinoin
1
1997
130
0.130
 Why?
Colorado
3
2014
4406
0.130
 Why?
Homeodomain Proteins
3
1999
495
0.130
 Why?
Ligands
3
2009
621
0.120
 Why?
Diet
1
2023
1212
0.120
 Why?
Caspase 7
1
2015
22
0.120
 Why?
Prolactin
2
1999
96
0.120
 Why?
Information Storage and Retrieval
1
2016
108
0.120
 Why?
Larynx
1
2016
57
0.120
 Why?
Bortezomib
1
2015
45
0.120
 Why?
Hypocalcemia
1
2015
28
0.120
 Why?
Inhibitory Concentration 50
1
2015
86
0.120
 Why?
User-Computer Interface
1
2016
147
0.120
 Why?
Radiation, Ionizing
1
2015
76
0.120
 Why?
Taxoids
1
2015
98
0.120
 Why?
Risk Assessment
4
2024
3232
0.120
 Why?
Double-Blind Method
2
2012
1875
0.120
 Why?
Pharmacogenetics
1
2016
172
0.120
 Why?
Laryngoscopy
1
2016
97
0.120
 Why?
Transcriptional Activation
2
1994
367
0.120
 Why?
Tumor Suppressor Protein p53
1
2019
509
0.120
 Why?
Immunotherapy
2
2016
592
0.110
 Why?
Immunophenotyping
2
2015
310
0.110
 Why?
Guidelines as Topic
1
2016
263
0.110
 Why?
Societies, Scientific
1
2014
45
0.110
 Why?
Energy Metabolism
1
2000
873
0.110
 Why?
Growth Hormone
1
1994
96
0.110
 Why?
Caspase 3
1
2015
245
0.110
 Why?
NF-KappaB Inhibitor alpha
1
2014
53
0.110
 Why?
Predictive Value of Tests
2
2019
1949
0.110
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
252
0.110
 Why?
DNA Mutational Analysis
2
2020
385
0.110
 Why?
Histiocytoma, Benign Fibrous
1
1994
8
0.110
 Why?
Lymphocytes, Tumor-Infiltrating
1
2016
207
0.110
 Why?
Diagnostic Techniques, Endocrine
1
2013
14
0.110
 Why?
Graves Disease
2
2012
35
0.110
 Why?
ROC Curve
1
2015
503
0.110
 Why?
I-kappa B Proteins
1
2014
79
0.110
 Why?
Cell Death
1
2015
354
0.110
 Why?
Preoperative Care
3
2024
339
0.110
 Why?
Transduction, Genetic
1
2014
128
0.110
 Why?
Young Adult
6
2024
12391
0.110
 Why?
Stilbenes
1
2013
36
0.110
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
102
0.110
 Why?
Registries
6
2015
1895
0.110
 Why?
Drug Resistance, Multiple
1
2013
25
0.100
 Why?
Transcription, Genetic
5
2011
1416
0.100
 Why?
Genetic Variation
1
2018
938
0.100
 Why?
Observer Variation
1
2013
315
0.100
 Why?
Sirolimus
1
2014
266
0.100
 Why?
Nuclear Proteins
1
1997
659
0.100
 Why?
Contraindications
1
2012
90
0.100
 Why?
T-Lymphocyte Subsets
2
2015
412
0.100
 Why?
Thiazoles
1
2012
117
0.090
 Why?
Receptors, Thyroid Hormone
3
1996
21
0.090
 Why?
src-Family Kinases
1
2012
95
0.090
 Why?
Protein Isoforms
2
2004
389
0.090
 Why?
Thyroiditis, Autoimmune
2
2020
15
0.090
 Why?
Glycoprotein Hormones, alpha Subunit
1
2011
22
0.090
 Why?
Genomics
1
2016
717
0.090
 Why?
TOR Serine-Threonine Kinases
1
2014
396
0.090
 Why?
Adolescent
7
2024
20313
0.090
 Why?
Mice, 129 Strain
1
2011
87
0.090
 Why?
Quality Improvement
1
2018
1095
0.090
 Why?
Oleanolic Acid
1
2010
9
0.090
 Why?
Polymerase Chain Reaction
4
2005
1036
0.090
 Why?
Cells, Cultured
3
2014
4077
0.090
 Why?
Pilot Projects
1
2015
1584
0.090
 Why?
Whole Body Imaging
1
2010
20
0.080
 Why?
Amino Acid Sequence
4
2006
2056
0.080
 Why?
Weight Gain
2
2023
509
0.080
 Why?
Ribonucleases
3
2002
54
0.080
 Why?
Electrophoresis, Gel, Two-Dimensional
2
2008
110
0.080
 Why?
Endometrial Neoplasms
2
2002
164
0.080
 Why?
Somatostatin
1
2009
55
0.080
 Why?
Antibody Specificity
1
2010
184
0.080
 Why?
Lymphocyte Subsets
1
2010
84
0.080
 Why?
Dopamine Agonists
1
2009
39
0.080
 Why?
Lymphoma, T-Cell
1
2009
23
0.080
 Why?
Diphosphonates
1
2010
58
0.080
 Why?
Breast Neoplasms
2
2020
2140
0.080
 Why?
Sulfones
1
2010
108
0.080
 Why?
Butadienes
1
2009
36
0.080
 Why?
Bone Density Conservation Agents
1
2010
70
0.080
 Why?
Hysterectomy
1
2010
118
0.080
 Why?
Calcium
1
2015
1212
0.080
 Why?
Radiotherapy
1
2010
185
0.080
 Why?
Postoperative Complications
2
2023
2473
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
193
0.080
 Why?
Time Factors
3
2010
6543
0.080
 Why?
Pyrimidines
1
2012
459
0.080
 Why?
Membrane Proteins
1
2015
1117
0.080
 Why?
Benzamides
1
2009
207
0.080
 Why?
Drug Evaluation, Preclinical
1
2009
171
0.070
 Why?
Phosphorylation
2
2012
1710
0.070
 Why?
Flow Cytometry
1
2012
1155
0.070
 Why?
CD4-Positive T-Lymphocytes
2
2015
1056
0.070
 Why?
Lymphocyte Activation
1
2012
1109
0.070
 Why?
Cohort Studies
5
2023
5409
0.070
 Why?
Proportional Hazards Models
3
2023
1197
0.070
 Why?
Enzyme Activation
1
2009
812
0.070
 Why?
Autoantibodies
2
2013
1467
0.070
 Why?
Follow-Up Studies
5
2024
4887
0.070
 Why?
Phenotype
3
2015
3074
0.070
 Why?
S100 Calcium Binding Protein A6
1
2006
1
0.070
 Why?
RNA, Small Interfering
1
2009
591
0.070
 Why?
Reproducibility of Results
2
2019
3080
0.070
 Why?
Pituitary Neoplasms
2
1999
179
0.060
 Why?
Colonic Neoplasms
1
2008
242
0.060
 Why?
Drug Delivery Systems
1
2009
333
0.060
 Why?
Metformin
1
2009
315
0.060
 Why?
Fatty Acids, Nonesterified
1
2006
160
0.060
 Why?
Postoperative Care
2
2018
241
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2006
117
0.060
 Why?
Neoplasm Grading
2
2018
283
0.060
 Why?
Chromatin Immunoprecipitation
1
2005
132
0.060
 Why?
Brain Neoplasms
1
2014
1143
0.060
 Why?
Inhibitor of Apoptosis Proteins
2
2002
45
0.060
 Why?
RNA, Neoplasm
2
2002
87
0.060
 Why?
Glucocorticoids
1
2009
578
0.060
 Why?
Blotting, Southern
2
1996
69
0.060
 Why?
Paclitaxel
1
2006
217
0.060
 Why?
Neck Dissection
1
2024
16
0.060
 Why?
Recurrent Laryngeal Nerve Injuries
1
2024
12
0.060
 Why?
Chromosome Mapping
2
1997
504
0.060
 Why?
Adjuvants, Pharmaceutic
1
2004
10
0.060
 Why?
Tomography, Emission-Computed
1
2004
66
0.060
 Why?
Organic Chemicals
1
2005
123
0.060
 Why?
Luciferases
1
2004
147
0.060
 Why?
DNA, Mitochondrial
1
2005
191
0.060
 Why?
Immunoprecipitation
1
2004
157
0.060
 Why?
Triglycerides
1
2006
527
0.060
 Why?
Quality of Life
3
2022
2687
0.060
 Why?
Heart Neoplasms
2
2015
49
0.060
 Why?
Probability
2
2021
305
0.050
 Why?
Cell Cycle Checkpoints
2
2016
95
0.050
 Why?
Dose-Response Relationship, Drug
2
2005
2011
0.050
 Why?
Lymph Node Excision
1
2024
164
0.050
 Why?
Professional Practice
1
2003
62
0.050
 Why?
Computers
1
2023
65
0.050
 Why?
National Institutes of Health (U.S.)
1
2023
122
0.050
 Why?
Protein Binding
1
2009
2120
0.050
 Why?
Genetic Testing
2
2018
428
0.050
 Why?
Poly A
1
2002
48
0.050
 Why?
5' Untranslated Regions
1
2002
55
0.050
 Why?
Magnetic Resonance Imaging
2
2010
3386
0.050
 Why?
Gene Library
1
2002
115
0.050
 Why?
Cell Division
1
2004
796
0.050
 Why?
DNA, Complementary
1
2002
271
0.050
 Why?
Point Mutation
1
2002
224
0.050
 Why?
Endometrium
1
2002
60
0.050
 Why?
Child
1
2021
20785
0.050
 Why?
Survival Analysis
3
2010
1269
0.050
 Why?
Thallium
1
2001
1
0.050
 Why?
Thallium Radioisotopes
1
2001
8
0.050
 Why?
Organotechnetium Compounds
1
2001
10
0.050
 Why?
Carcinoma, Endometrioid
1
2002
47
0.050
 Why?
Biopsy, Needle
1
2002
189
0.050
 Why?
Plasmids
1
2002
358
0.050
 Why?
Patient Care Management
1
2001
56
0.040
 Why?
Life Style
1
2023
459
0.040
 Why?
Thyroid Function Tests
2
2017
14
0.040
 Why?
Cell Cycle
1
2004
589
0.040
 Why?
Macrophages
2
2020
1484
0.040
 Why?
Health Status
1
2006
754
0.040
 Why?
MutS Homolog 2 Protein
1
2020
14
0.040
 Why?
MCF-7 Cells
1
2020
116
0.040
 Why?
Mice, Transgenic
1
2005
2117
0.040
 Why?
Specialization
1
2001
144
0.040
 Why?
Calcitonin
1
2020
27
0.040
 Why?
Models, Animal
1
2022
376
0.040
 Why?
Pituitary Hormones
1
1999
16
0.040
 Why?
Receptors, Virus
1
2020
83
0.040
 Why?
Mice, SCID
1
2020
350
0.040
 Why?
Risk Factors
3
2023
9745
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2020
157
0.040
 Why?
Medicine
1
2001
119
0.040
 Why?
Validation Studies as Topic
1
2019
21
0.040
 Why?
Singapore
1
2019
20
0.040
 Why?
Cost-Benefit Analysis
1
2022
569
0.040
 Why?
Octreotide
1
1999
27
0.040
 Why?
Lymphoma, T-Cell, Cutaneous
1
1999
43
0.040
 Why?
Immune System
1
2020
175
0.040
 Why?
Mice, Inbred NOD
1
2020
588
0.040
 Why?
Drug Therapy, Combination
1
2022
1040
0.040
 Why?
Leukocytes
1
2020
306
0.040
 Why?
Surveys and Questionnaires
3
2020
5384
0.040
 Why?
Luminescence
1
2018
36
0.040
 Why?
Kaplan-Meier Estimate
1
2020
851
0.040
 Why?
Radiation Tolerance
1
1999
98
0.040
 Why?
Pharmacogenomic Variants
1
2018
35
0.040
 Why?
DNA Mismatch Repair
1
2018
47
0.040
 Why?
North America
1
2018
291
0.040
 Why?
Age Factors
3
2015
3140
0.040
 Why?
Interdisciplinary Communication
1
2018
184
0.040
 Why?
Oncogenes
1
2018
112
0.040
 Why?
Dietary Carbohydrates
1
1998
151
0.040
 Why?
Delphi Technique
1
2018
225
0.030
 Why?
Liver
1
2005
1839
0.030
 Why?
Doxorubicin
1
1999
328
0.030
 Why?
Soft Tissue Neoplasms
1
2018
112
0.030
 Why?
Gene Frequency
1
2018
502
0.030
 Why?
Health Policy
1
2020
351
0.030
 Why?
Advisory Committees
1
2018
216
0.030
 Why?
DNA
4
1996
1396
0.030
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
74
0.030
 Why?
Tissue Distribution
1
1997
315
0.030
 Why?
Stroboscopy
1
2016
5
0.030
 Why?
DNA Fingerprinting
1
1996
26
0.030
 Why?
Deoxyribonuclease I
1
1996
38
0.030
 Why?
Immunomodulation
1
2016
92
0.030
 Why?
RNA
1
2002
880
0.030
 Why?
Surgeons
1
2020
260
0.030
 Why?
Tumor Suppressor Proteins
1
2018
314
0.030
 Why?
Antithyroid Agents
2
2006
13
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
485
0.030
 Why?
Clinical Trials as Topic
1
2020
1004
0.030
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2015
30
0.030
 Why?
Chromosomes, Human, Pair 4
1
1995
29
0.030
 Why?
Mutagenesis, Site-Directed
1
1996
361
0.030
 Why?
Lymphocyte Count
1
2015
148
0.030
 Why?
Mutagenesis, Insertional
1
1994
65
0.030
 Why?
Cytotoxicity, Immunologic
1
2015
220
0.030
 Why?
Adipose Tissue
1
1998
590
0.030
 Why?
Microsatellite Repeats
1
2014
164
0.030
 Why?
Gene Expression Regulation
4
1997
2537
0.030
 Why?
Age of Onset
1
2015
496
0.030
 Why?
Mice, Knockout
1
2020
2871
0.030
 Why?
Risk
2
2006
854
0.030
 Why?
Proto-Oncogene Proteins c-bcl-2
1
1995
232
0.030
 Why?
Computational Biology
1
2018
595
0.030
 Why?
Head and Neck Neoplasms
1
2018
543
0.030
 Why?
Genes, Neoplasm
1
2013
20
0.030
 Why?
Killer Cells, Natural
1
2016
427
0.030
 Why?
Preoperative Period
1
2013
114
0.030
 Why?
Gene Deletion
1
1994
380
0.030
 Why?
Neutropenia
1
2013
136
0.030
 Why?
Alternative Splicing
1
1994
216
0.030
 Why?
Case-Control Studies
2
2015
3377
0.020
 Why?
DNA, Single-Stranded
1
1993
114
0.020
 Why?
Postoperative Period
1
2013
329
0.020
 Why?
Focal Adhesion Kinase 1
1
2012
32
0.020
 Why?
Reference Values
2
2005
793
0.020
 Why?
Genetic Markers
1
2013
336
0.020
 Why?
Dasatinib
1
2012
54
0.020
 Why?
Recurrence
1
2015
1005
0.020
 Why?
Autophagy
1
2014
266
0.020
 Why?
Repressor Proteins
1
1995
406
0.020
 Why?
Age Distribution
1
2012
372
0.020
 Why?
Sex Distribution
1
2012
359
0.020
 Why?
Saccharomyces cerevisiae Proteins
1
1995
383
0.020
 Why?
Tumor Burden
1
2012
286
0.020
 Why?
Longevity
1
2012
152
0.020
 Why?
Primary Health Care
1
2001
1678
0.020
 Why?
Universities
1
2013
407
0.020
 Why?
Interleukin-6
1
2014
720
0.020
 Why?
Obesity
1
2023
2879
0.020
 Why?
Protein Processing, Post-Translational
1
2012
454
0.020
 Why?
Menopause
1
2012
297
0.020
 Why?
Cell Survival
1
2012
1075
0.020
 Why?
Cross-Sectional Studies
1
2020
5050
0.020
 Why?
Early Detection of Cancer
1
2013
369
0.020
 Why?
Physical Examination
1
2009
234
0.020
 Why?
Calreticulin
1
2008
27
0.020
 Why?
Binding Sites
3
1996
1250
0.020
 Why?
Exons
2
2002
341
0.020
 Why?
Insulin
1
1998
2325
0.020
 Why?
Drug Administration Schedule
1
2009
768
0.020
 Why?
Cytokines
1
2015
2013
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor Proteins
1
2006
7
0.020
 Why?
Chromans
1
2006
24
0.020
 Why?
Radiotherapy Dosage
1
2006
251
0.020
 Why?
International Cooperation
1
2006
174
0.020
 Why?
Feasibility Studies
1
2009
867
0.010
 Why?
Angiogenesis Inhibitors
1
2006
220
0.010
 Why?
Radiography
1
2006
796
0.010
 Why?
Inflammation
1
2014
2737
0.010
 Why?
Peptides
1
2008
923
0.010
 Why?
Neoplasm, Residual
1
2003
120
0.010
 Why?
Biopsy
1
2006
1092
0.010
 Why?
Culture Techniques
1
2002
81
0.010
 Why?
Models, Biological
1
2008
1722
0.010
 Why?
Fushi Tarazu Transcription Factors
1
1999
5
0.010
 Why?
Steroidogenic Factor 1
1
1999
6
0.010
 Why?
Gonadotropins
1
1999
38
0.010
 Why?
Postmenopause
1
2002
350
0.010
 Why?
Pain
1
2006
786
0.010
 Why?
Analysis of Variance
1
2002
1288
0.010
 Why?
Carcinoma, Medullary
1
1998
14
0.010
 Why?
DNA Primers
1
1999
510
0.010
 Why?
Follicle Stimulating Hormone
1
1999
235
0.010
 Why?
Organ Specificity
1
1998
295
0.010
 Why?
GATA2 Transcription Factor
1
1997
14
0.010
 Why?
Logistic Models
1
2002
1985
0.010
 Why?
Sequence Deletion
1
1996
179
0.010
 Why?
3T3 Cells
1
1995
153
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
1995
111
0.010
 Why?
Muridae
1
1995
5
0.010
 Why?
Replication Protein C
1
1995
4
0.010
 Why?
Macromolecular Substances
1
1995
216
0.010
 Why?
Hybrid Cells
1
1995
50
0.010
 Why?
Mutagenesis
1
1995
181
0.010
 Why?
Minor Histocompatibility Antigens
1
1995
46
0.010
 Why?
Mice, Inbred DBA
1
1994
190
0.010
 Why?
Body Weight
1
1998
939
0.010
 Why?
Survival Rate
1
1998
1869
0.010
 Why?
Cloning, Molecular
1
1994
525
0.010
 Why?
Blotting, Northern
1
1993
201
0.010
 Why?
Haplotypes
1
1995
475
0.010
 Why?
Sex Factors
1
1998
1965
0.010
 Why?
Protein Biosynthesis
1
1993
405
0.010
 Why?
Rats
1
1996
5482
0.000
 Why?
Mice, Inbred C57BL
1
1995
5439
0.000
 Why?
Haugen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (503) concept(s)
_
Co-Authors Expand Description
See all (44) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)